Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD

NCT01207622 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Attention Deficit Hyperactivity Disorder
Substance Use Disorder

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]